Naturhouse Health (GB:0R9G)
LSE:0R9G
0R9G Stock Chart & Stats
€2.27
€0.00(0.00%)
At close: 4:00 PM EST
€2.27
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€1.68 - €2.80
Previous CloseN/A
Volume1.00
Average Volume (3M)52.00
Market Cap
€156.47M
Enterprise Value€136.81M
Total Cash (Recent Filing)€23.34M
Total Debt (Recent Filing)€2.72M
Price to Earnings (P/E)9.4
Beta0.21
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.16
Shares Outstanding60,000,000
10 Day Avg. Volume73
30 Day Avg. Volume52
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.15
Revenue Forecast (FY)€48.10M
Bulls Say, Bears Say
Bulls Say
High Profitability / MarginsConsistently elevated EBIT and net margins reflect an efficient service-plus-product business model where dietitian-led engagement drives recurring product sales. High margins provide durable earnings quality, absorb revenue volatility, and support reinvestment or shareholder returns over the medium term.
Strong Cash GenerationReliable free cash flow conversion, including a rise to €11.5M in 2025 despite weaker revenue, indicates disciplined working-capital management and operational cash resilience. Sustainable FCF enables dividends, franchise support and self-funded operational investments without heavy external financing.
Conservative Leverage And High ROEHistorically low leverage combined with strong returns on equity signals financial flexibility and efficient capital allocation. A conservative balance sheet supports franchise operations, funds growth initiatives when needed, and provides a buffer to absorb shocks while preserving long-term strategic optionality.
Bears Say
Severe 2025 Revenue DeclineA dramatic -37.9% revenue drop in 2025, on top of a multi-year shrinking top line, threatens the recurring product-sales engine and undermines scale benefits. If top-line contraction persists, it can erode the company’s ability to sustain margins, franchise economics, and long-term earnings durability.
Weakened Balance Sheet Cushion In 2025A material decline in equity and assets in 2025 reduces the balance-sheet buffer, limiting borrowing capacity and operational flexibility. A smaller equity base constrains ability to support franchisees, invest in growth initiatives, or absorb further adverse shocks without changing capital structure or cutting distributions.
Negative Growth Trend And Cash-Flow VolatilityA negative revenue-growth trend and uneven operating cash flow (notably weak OCF in 2022) point to inconsistent demand and working-capital swings. This variability complicates multi-year planning, risks dividend or franchise support stability, and makes capital allocation less predictable.
Naturhouse Health News
0R9G FAQ
What was Naturhouse Health’s price range in the past 12 months?
Naturhouse Health lowest share price was €1.68 and its highest was €2.80 in the past 12 months.
What is Naturhouse Health’s market cap?
Naturhouse Health’s market cap is €156.47M.
When is Naturhouse Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Naturhouse Health’s earnings last quarter?
Naturhouse Health released its earnings results on Feb 26, 2024. The company reported €0.065 earnings per share for the quarter, beating the consensus estimate of N/A by €0.065.
Is Naturhouse Health overvalued?
According to Wall Street analysts Naturhouse Health’s price is currently Overvalued.
Does Naturhouse Health pay dividends?
Naturhouse Health does not currently pay dividends.
What is Naturhouse Health’s EPS estimate?
Naturhouse Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Naturhouse Health have?
Naturhouse Health has 60,000,000 shares outstanding.
What happened to Naturhouse Health’s price movement after its last earnings report?
Naturhouse Health reported an EPS of €0.065 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.461%.
Which hedge fund is a major shareholder of Naturhouse Health?
Currently, no hedge funds are holding shares in GB:0R9G
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Naturhouse Health
Naturhouse Health, S.A. operates in the nutrition and weight management industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and foods and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. As of December 31, 2020, it operated through a network of 1,788 centers in 28 countries. The company sells its products through directly operated and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. The company was founded in 1991 and is based in Madrid, Spain.
Technical Analysis
DISTRIBUIDORA INTERNACIONAL DE ALIMENTACION
―
EBRO FOODS
―
Pescanova
―
DEOLEO S.A.
―
Puig Brands, S.A.
―
Options Prices
Currently, No data available
---